標(biāo)題: Titlebook: Critical Care of COVID-19 in the Emergency Department; Joseph R. Shiber Book 2021 The Editor(s) (if applicable) and The Author(s), under e [打印本頁] 作者: hormone-therapy 時(shí)間: 2025-3-21 17:09
書目名稱Critical Care of COVID-19 in the Emergency Department影響因子(影響力)
書目名稱Critical Care of COVID-19 in the Emergency Department影響因子(影響力)學(xué)科排名
書目名稱Critical Care of COVID-19 in the Emergency Department網(wǎng)絡(luò)公開度
書目名稱Critical Care of COVID-19 in the Emergency Department網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Critical Care of COVID-19 in the Emergency Department被引頻次
書目名稱Critical Care of COVID-19 in the Emergency Department被引頻次學(xué)科排名
書目名稱Critical Care of COVID-19 in the Emergency Department年度引用
書目名稱Critical Care of COVID-19 in the Emergency Department年度引用學(xué)科排名
書目名稱Critical Care of COVID-19 in the Emergency Department讀者反饋
書目名稱Critical Care of COVID-19 in the Emergency Department讀者反饋學(xué)科排名
作者: Invigorate 時(shí)間: 2025-3-21 21:46 作者: cocoon 時(shí)間: 2025-3-22 03:58
Mechanischer Triebstrang und Maschinenhaus,es for inpatients with Covid-19 have undergone mostly retrospective analysis suggesting improved outcomes, although new prospective data suggests otherwise. Incorporating new information into the diagnosis and management of these complex patients and continuing to adapt practice according to emergin作者: 借喻 時(shí)間: 2025-3-22 05:42 作者: Terrace 時(shí)間: 2025-3-22 10:13 作者: 鋼筆記下懲罰 時(shí)間: 2025-3-22 14:19 作者: 鋼筆記下懲罰 時(shí)間: 2025-3-22 19:32 作者: Melanocytes 時(shí)間: 2025-3-23 00:06 作者: 鐵砧 時(shí)間: 2025-3-23 02:06
Personal Protection During Patient Care and Procedures,作者: 可能性 時(shí)間: 2025-3-23 09:13 作者: Ganglion 時(shí)間: 2025-3-23 13:01 作者: 并入 時(shí)間: 2025-3-23 17:11 作者: majestic 時(shí)間: 2025-3-23 21:59
https://doi.org/10.1007/978-3-030-85636-6COVID-19; coronavirus; emergency department; emergency room; critical care; pandemic作者: 侵略主義 時(shí)間: 2025-3-23 23:03
978-3-030-85635-9The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: 博愛家 時(shí)間: 2025-3-24 06:15
Bauformen von Windkraftanlagen,This chapter will focus on surgical emergencies during the era of COVID-19. Performing surgery on patients with COVID-19 carries multiple risks to both the patient and the healthcare team.作者: 沉思的魚 時(shí)間: 2025-3-24 10:30 作者: 上腭 時(shí)間: 2025-3-24 11:02 作者: 神秘 時(shí)間: 2025-3-24 15:08
Anwendungskonzeptionen und Einsatzbereiche,1. Emergency clinicians will be in the front line when patients with COVID-19 infection present to emergency departments with different levels of symptoms..The disease is still evolving, and we are still learning how to treat the disease. However, for the emergency clinicians, managing these critica作者: 駕駛 時(shí)間: 2025-3-24 19:51 作者: Ganglion 時(shí)間: 2025-3-25 01:34
Anwendungskonzeptionen und Einsatzbereiche,irus (COVID-19) is a rising cause of hypoxic respiratory failure across the globe, and a mainstay of treatment is providing supplemental oxygen (Whittle et al., J Am Coll Emerg Physicians Open 1(2):95–101, 2020; Tobin et al., Ann Intensive Care 10(1):78, 2020; Rola et al., Clin Exp Emerg Med 7(2):78作者: 使尷尬 時(shí)間: 2025-3-25 05:40 作者: cochlea 時(shí)間: 2025-3-25 09:45
Belastungen und Strukturbeanspruchungen,al benefit has also been demonstrated with the use of ECMO for ARDS related to other viral infections, and the use of veno-venous ECMO is recommended for COVID-19-associated respiratory failure by organizations including the Extracorporeal Life Support Organization (ELSO), the World Health Organizat作者: Hyperlipidemia 時(shí)間: 2025-3-25 14:20 作者: Obvious 時(shí)間: 2025-3-25 16:46
Planung, Errichtung und Betrieb,y are myriad: hypoxia, hypotension, enhanced inflammatory response, ACE2-receptor downregulation, drug toxicity, and endogenous catecholamine adrenergic stimulation. Complications include persistent tachycardia, elevated cardiac markers, and decompensated heart failure and are associated with poorer作者: 同義聯(lián)想法 時(shí)間: 2025-3-25 23:35 作者: 不如樂死去 時(shí)間: 2025-3-26 04:10
Planung, Errichtung und Betrieb,ared to patients without kidney injury, and kidney injury seems highly correlated with severe respiratory dysfunction. Given the challenges of treating these patients in a pandemic, where resources can be scarce or outpaced by need, less common strategies may need to be employed, including high-inte作者: 母豬 時(shí)間: 2025-3-26 05:53
Belastungen und Strukturbeanspruchungen,ly seen in greater than 50% of patients with moderate to severe disease. Based on current data, it is unclear if patients with preexisting liver disease (NASH/NAFLD) are at higher risk of mortality due to COVID-19. It does appear, however, that those with cirrhosis have an increased risk of severe d作者: Offbeat 時(shí)間: 2025-3-26 12:21 作者: 空洞 時(shí)間: 2025-3-26 15:47 作者: 宮殿般 時(shí)間: 2025-3-26 17:41
Leistungsabgabe und Energielieferung,apeutic agents available for the management of COVID-19 infections. There is an abundance of literature being published and in a very quick manner, and we want to lay out the most evidence-based pharmacological agents available. Management of COVID-19 will depend on severity of the infection at pres作者: Glaci冰 時(shí)間: 2025-3-26 23:31 作者: Androgen 時(shí)間: 2025-3-27 02:48 作者: Anticlimax 時(shí)間: 2025-3-27 07:41
Belastungen und Strukturbeanspruchungen,dical equipment, staff, and space should be anticipated early and managed proactively. This occasionally will necessitate deviation from conventional operating procedures and developing novel solutions to new problems. Clearly defined leadership and command control facilitate streamlined operations 作者: CAND 時(shí)間: 2025-3-27 10:22 作者: expunge 時(shí)間: 2025-3-27 15:20 作者: abysmal 時(shí)間: 2025-3-27 21:49 作者: cancer 時(shí)間: 2025-3-27 22:01 作者: angiography 時(shí)間: 2025-3-28 05:17 作者: hankering 時(shí)間: 2025-3-28 07:04 作者: 大吃大喝 時(shí)間: 2025-3-28 13:30
Noninvasive Respiratory Support for COVID-19,irus (COVID-19) is a rising cause of hypoxic respiratory failure across the globe, and a mainstay of treatment is providing supplemental oxygen (Whittle et al., J Am Coll Emerg Physicians Open 1(2):95–101, 2020; Tobin et al., Ann Intensive Care 10(1):78, 2020; Rola et al., Clin Exp Emerg Med 7(2):78作者: macrophage 時(shí)間: 2025-3-28 16:48 作者: 真繁榮 時(shí)間: 2025-3-28 18:58 作者: 走路左晃右晃 時(shí)間: 2025-3-28 22:56 作者: MIR 時(shí)間: 2025-3-29 05:09 作者: 火光在搖曳 時(shí)間: 2025-3-29 09:55 作者: 哭得清醒了 時(shí)間: 2025-3-29 15:10 作者: Graphite 時(shí)間: 2025-3-29 18:54 作者: 大漩渦 時(shí)間: 2025-3-29 20:53 作者: 人類的發(fā)源 時(shí)間: 2025-3-30 00:00 作者: Fabric 時(shí)間: 2025-3-30 06:22 作者: dissolution 時(shí)間: 2025-3-30 12:12
Point of Care Echocardiography in the COVID-19 Patient,ritically ill COVID-19 patient, facilitating early implementation of definitive therapy for a multitude of conditions associated with COVID-19 infection including thromboembolic disease, pleural effusion, pulmonary edema, and myocarditis. Through a protocolized approach to cleaning and disinfection,作者: NAVEN 時(shí)間: 2025-3-30 14:52
Inter-Hospital Transfer of the Critically Ill COVID-19 Patient,tinued management of these patients may exceed the capacity or capability of the hospital to which the patient presented. Inter-facility transfer of a critically ill patient with COVID-19 may therefore be necessary. Multiple models for transfer of pediatric, ST-elevation myocardial infarction, and t作者: 匍匐 時(shí)間: 2025-3-30 19:28 作者: 癡呆 時(shí)間: 2025-3-30 22:06 作者: 不能平靜 時(shí)間: 2025-3-31 02:17
Management of Undifferentiated Critically Ill COVID-19 Patients,lly ill COVID-19 patients’ airway, breathing, and circulations (ABCs) is still paramount. This chapter reported recommendations from current literature regarding managing the undifferentiated critically ill COVID-19 patients. We also summarized our current knowledge regarding treatment for COVID-19.作者: bizarre 時(shí)間: 2025-3-31 06:03 作者: 使更活躍 時(shí)間: 2025-3-31 11:25 作者: 厭倦嗎你 時(shí)間: 2025-3-31 14:07
Pharmacological Agents for COVID-19 Patients,entation. Current evidence will support corticosteroids, thromboprophylaxis, and remdesivir. Limited evidence exists around the monoclonal antibodies, at this time. Some treatment options are to be initiated earlier and in higher-risk patient populations to reduce progression to more severe disease and hospitalization.作者: 逃避責(zé)任 時(shí)間: 2025-3-31 19:22 作者: headlong 時(shí)間: 2025-4-1 00:05 作者: MAL 時(shí)間: 2025-4-1 01:50 作者: Interregnum 時(shí)間: 2025-4-1 06:30 作者: Outshine 時(shí)間: 2025-4-1 12:02
Belastungen und Strukturbeanspruchungen,ations and see their doctor regularly. Current therapies aimed at the treatment of COVID-19 have been associated with hepatotoxicity including tocilizumab, lopinavir-ritonavir, and remdesivir and require monitoring for such side effects.作者: MONY 時(shí)間: 2025-4-1 14:50
Mechanischer Triebstrang und Maschinenhaus,formation as more than half of reported cases of intracranial hemorrhage were in patients on therapeutic anticoagulation. While seizures are infrequent, many antiepileptic medications can interact with COVID-19 therapies. More research is needed to understand the potential long-term neurological sequelae of COVID-19.作者: STANT 時(shí)間: 2025-4-1 20:58
Leistungsabgabe und Energielieferung,es early ventricular dysfunction, wall motion abnormalities, and aids in intravascular volume assessment. Pulmonary POCUS can identify distinguishing features of ARDS, pneumonia, and congestive heart failure and is a useful adjunct in trending disease progression or resolution.
